Sep 16, 2026, 08:20 UTC
Ono Pharmaceutical announced it obtained manufacturing and marketing approval from the Ministry of Health, Labour and Welfare for its anti-epileptic drug Cenobamate for the treatment of partial-onset seizures.
Source:Sep 1, 2026, 23:00 UTC
Aitia and Ono Pharmaceutical announced a collaboration to use Aitia's causal AI-based Gemini Digital Twin Platform to discover novel drug targets in neurological diseases.
Source:Jul 17, 2026, 00:49 UTC
Chordia Therapeutics terminated its license agreement with Ono Pharmaceutical for CTX-177 and regained all global rights.
Source: